{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:48:17Z","timestamp":1793915297143,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006378","name":"Universitas Indonesia","doi-asserted-by":"publisher","award":["573\/PKS\/R\/UI\/2025"],"award-info":[{"award-number":["573\/PKS\/R\/UI\/2025"]}],"id":[{"id":"10.13039\/501100006378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Zeitschrift f\u00fcr Medizinische Physik"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.zemedi.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:58:54Z","timestamp":1783108734000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [177Lu]Lu-PSMA-617 Therapy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1484-6808","authenticated-orcid":false,"given":"Fulki","family":"Fiarka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assyifa Rahman","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2835-8517","authenticated-orcid":false,"given":"Indra","family":"Budiansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8695-2302","authenticated-orcid":false,"given":"Abdurrahman Aziz","family":"Wicaksono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8678-4304","authenticated-orcid":false,"given":"Jaja M.","family":"Jabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0752-7134","authenticated-orcid":false,"given":"Steffie M.B.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4056-9117","authenticated-orcid":false,"given":"Bastiaan M.","family":"Prive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nagarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-8575","authenticated-orcid":false,"given":"Syahril","family":"Siregar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deni","family":"Hardiansyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-1576","authenticated-orcid":false,"given":"Gerhard","family":"Glatting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.zemedi.2026.06.005_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.zemedi.2026.06.005_b0010","first-page":"351","volume":"19","author":"Alberts","year":"2024","journal-title":"Prostate-specific Membrane Antigen: Diagnostics. PET Clin"},{"key":"10.1016\/j.zemedi.2026.06.005_b0015","first-page":"237","article-title":"Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy of Prostate Cancer: Current Status and Future Perspectives","volume":"36","author":"Lin","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.zemedi.2026.06.005_b0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2967\/jnumed.115.168443","article-title":"177Lu-labeled prostate-specific membrane antigen radioligand therapy of metastatic castration-resistant prostate cancer: Safety and efficacy","volume":"57","author":"Baum","year":"2016","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00259-021-05525-7","article-title":"177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)","volume":"49","author":"Khreish","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.06.005_b0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for Metastatic Castration-Resistant Prostate Cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0035","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2967\/jnumed.121.262713","article-title":"Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry","volume":"63","author":"Schuchardt","year":"2022","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.zemedi.2013.03.005","article-title":"Treatment planning in molecular radiotherapy","volume":"23","author":"Glatting","year":"2013","journal-title":"Z Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet No. 21: A generalized schema for radiopharmaceutical dosimetry-standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0050","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1007\/s00259-019-04485-3","article-title":"EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)","volume":"46","author":"Kratochwil","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.zemedi.2026.06.005_b0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2967\/jnumed.117.193706","article-title":"Dose mapping after endoradiotherapy with 177 Lu-DOTATATE\/DOTATOC by a single measurement after 4 days","volume":"59","author":"H\u00e4nscheid","year":"2018","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.zemedi.2022.06.004","article-title":"Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model","volume":"33","author":"Hardiansyah","year":"2023","journal-title":"Z Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-024-00658-8","article-title":"A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?","volume":"11","author":"Vergnaud","year":"2024","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.zemedi.2023.01.007","article-title":"Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling","volume":"34","author":"Hardiansyah","year":"2024","journal-title":"Z Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0075","doi-asserted-by":"crossref","unstructured":"Hardiansyah D, Yousefzadeh-Nowshahr E, Kind F, Beer AJ, Ruf J, Glatting, et al. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy. Journal of Nuclear Medicine 2024;65:566\u201372. 10.2967\/jnumed.123.266268.","DOI":"10.2967\/jnumed.123.266268"},{"key":"10.1016\/j.zemedi.2026.06.005_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-023-00530-1","article-title":"Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept","volume":"10","author":"Hardiansyah","year":"2023","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-021-00427-x","article-title":"A population-based method to determine the time-integrated activity in molecular radiotherapy","volume":"8","author":"Hardiansyah","year":"2021","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-025-00726-7","article-title":"Accuracy and precision analyses of single-time-point dosimetry utilising physiologically-based pharmacokinetic modelling and non-linear mixed-effects modelling","volume":"12","author":"Budiansah","year":"2025","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-021-00409-z","article-title":"Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT\/CT study","volume":"8","author":"Chicheportiche","year":"2021","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0100","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mp.12886","article-title":"Technical Note: Single time point dose estimate for exponential clearance","volume":"45","author":"Madsen","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.104868","article-title":"Single-time-point dosimetry using model selection and the Bayesian fitting method: A proof of concept","volume":"129","author":"Patrianesha","year":"2025","journal-title":"Physica Medica"},{"key":"10.1016\/j.zemedi.2026.06.005_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2019.100514","article-title":"Nuclear Data Sheets for A=177","volume":"159","author":"Kondev","year":"2019","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.zemedi.2026.06.005_b0115","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1158\/1078-0432.CCR-20-4298","article-title":"Lutetium-177-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer: A prospective pilot study","volume":"27","author":"Priv\u00e9","year":"2021","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.zemedi.2026.06.005_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-020-0278-3","article-title":"Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT\/CT systems","volume":"7","author":"Peters","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-023-00952-z","article-title":"Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation","volume":"13","author":"Peters","year":"2023","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.zemedi.2026.06.005_b0130","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1118\/1.2794176","article-title":"Choosing the optimal fit function: Comparison of the Akaike information criterion and the F-test","volume":"34","author":"Glatting","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0135","doi-asserted-by":"crossref","DOI":"10.1118\/1.4820367","article-title":"Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient","volume":"40","author":"Kletting","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.zemedi.2015.01.001","article-title":"The NUKDOS software for treatment planning in molecular radiotherapy","volume":"25","author":"Kletting","year":"2015","journal-title":"Z Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0145","first-page":"117","article-title":"Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls","author":"Ivashchenko","year":"2024","journal-title":"Physica Medica"},{"key":"10.1016\/j.zemedi.2026.06.005_b0150","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2967\/jnumed.119.240366","article-title":"OpenDose: Open-access resource for nuclear medicine dosimetry","volume":"61","author":"Chauvin","year":"2020","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.zemedi.2009.05.003","article-title":"Model selection for time-activity curves: The corrected Akaike information criterion and the F-test","volume":"19","author":"Kletting","year":"2009","journal-title":"Z Med Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-018-0210-2","article-title":"Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy","volume":"5","author":"Sundl\u00f6v","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/0284186X.2011.618511","article-title":"Minor changes in effective half-life during fractionated 177Lu-Octreotate therapy","volume":"51","author":"Garske","year":"2012","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.zemedi.2026.06.005_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-018-0224-9","article-title":"Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT","volume":"5","author":"Del Prete","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0175","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-020-00339-2","article-title":"Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points","volume":"7","author":"Sandstr\u00f6m","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.zemedi.2026.06.005_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-2-49","article-title":"Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: Comparison between methods based on planar scintigraphy","volume":"2","author":"Larsson","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.zemedi.2026.06.005_b0185","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2967\/jnumed.123.266871","article-title":"Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T Therapy","volume":"65","author":"Resch","year":"2024","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.zemedi.2026.06.005_b0190","series-title":"Food and Drug Administration. Population Pharmacokinetics Guidance for Industry","year":"2022"}],"container-title":["Zeitschrift f\u00fcr Medizinische Physik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939388926000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939388926000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:45:29Z","timestamp":1785901529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939388926000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"alternative-id":["S0939388926000644"],"URL":"https:\/\/doi.org\/10.1016\/j.zemedi.2026.06.005","relation":{},"ISSN":["0939-3889"],"issn-type":[{"value":"0939-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [177Lu]Lu-PSMA-617 Therapy","name":"articletitle","label":"Article Title"},{"value":"Zeitschrift f\u00fcr Medizinische Physik","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.zemedi.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH on behalf of DGMP, \u00d6GMP and SSRMP.","name":"copyright","label":"Copyright"}]}}